LITCHMAN MANUEL MD (President and CEO) purchased 0.9% of their position (10K shares) of MUSTANG BIO, INC. on the open market
Open‑market purchase worth $6.3K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 4/3/2023ACC: 0001104659-23-040934
DirectorOfficer· President and CEO
Since Nov 2018
+71K
Net shares
Net buyer
$6.3K
Total acquired
2
Open market trades
2B · 0S
3
Total transactions
71K acquired
Non-Derivative Transactions3
COMMON STOCK, PAR VALUE $0.0001
Direct
Shares
+5K
Price / share
$0.74
Trade value
$3.69K
% of position
0.5%
3/18/2022
1.03M→1.03M
COMMON STOCK, PAR VALUE $0.0001
Direct
Shares
+61K
Price / share
—
Trade value
—
% of position
5.9%
6/21/2022
1.03M→1.09M
COMMON STOCK, PAR VALUE $0.0001
Direct
Shares
+5K
Price / share
$0.52
Trade value
$2.58K
% of position
0.5%
9/13/2022
1.09M→1.10M
Total
Net shares
+71K
Net value
$6.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK, PAR VALUE $0.0001 Direct | 3/18/2022 | P · Purchase | +5K | $0.74 | $3.69K | 0.5% | 1.03M | 1.03M |
| COMMON STOCK, PAR VALUE $0.0001 Direct | 6/21/2022 | A · Award | +61K | — | — | 5.9% | 1.03M | 1.09M |
| COMMON STOCK, PAR VALUE $0.0001 Direct | 9/13/2022 | P · Purchase | +5K | $0.52 | $2.58K | 0.5% | 1.09M | 1.10M |
| Total | +71K | $6.28K | ||||||
Derivative Transactions0
No derivative transactions reported